ConductScience.org, home

Paper58457

Specificity in T cell mediated lympholysis: identical genetic control of the proliferative and effector phases of allogeneic and xenogeneic reactions.

Peck AB and 2 others. Transplant Rev, 1976. Cited by 49 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Specificity in T cell mediated lympholysis: identical genetic control of the proliferative and effector phases of allogeneic and xenogeneic reactions. Papers, record 58457. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/58457

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Specificity in T cell mediated lympholysis: identical genetic control of the proliferative and effector phases of allogeneic and xenogeneic reactions.
PubMed
Journal
Transplant Rev
PubMed
Year
1976
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
49
iCite
Relative citation ratio, by iCite
1.21
iCite
Revised in PubMed
2019-10-27
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Peck ABA B
2Alter BJB J
3Lindahl KFK F

Source PubMed

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Histocompatibility AntigensMajor topic
Immunity, CellularMajor topic
ImmunogeneticsMajor topic
T-LymphocytesMajor topic
Animals
Cell Division
Cytotoxicity Tests, Immunologic
Epitopes
Humans
Isoantigens
Lymphocyte Activation
Lymphocyte Culture Test, Mixed
Mice
Models, Biological
Transplantation, Heterologous
Transplantation, Homologous

Source PubMed

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.

PMIDTitleJournalYearIn PapersSource
7,216,321Genetic and functional analyses of the primary in vitro CTL: response of NZB lymphocytes to H-2-compatible cells.Immunogenetics1981https://conductscience.org/library/papers/7216321PubMed
6,215,338Immune responsiveness against the human placenta. II. Response with xenogeneic lymphocytes in culture.Immunology1982https://conductscience.org/library/papers/6215338PubMed
2,142,721Xenogeneic proliferation and lymphokine production are dependent on CD4+ helper T cells and self antigen-presenting cells in the mouse.J Exp Med1990https://conductscience.org/library/papers/2142721PubMed
306,831Effect of adult thymectomy on tumour immunity in mice.Br J Cancer1978https://conductscience.org/library/papers/306831PubMed
302,312
Induction of specific immune unresponsiveness using purified mixed leukocyte culture-activated T lymphoblasts as autoimmunogen. I. Demonstration of general validity as to species and histocompatibility barriers.
J Exp Med1977https://conductscience.org/library/papers/302312PubMed
300,775Secondary in vitro responses of T lymphocytes to non-H-2 alloantigens self-H-2-restricted responses induced in heterologous serum are not dependent on primary-stimulating non-H-2 alloantigens.J Exp Med1977https://conductscience.org/library/papers/300775PubMed
300,484Cytolytic thymus-derived lymphocytes specific for allogeneic stimulator cells crossreact with chemically modified syngeneic cells.Proc Natl Acad Sci U S A1977https://conductscience.org/library/papers/300484PubMed
152,801Cross-reactive cytotoxic responses. H-2 restricted are more specific than anti-H-2 responses.J Exp Med1978https://conductscience.org/library/papers/152801PubMed
151,664Human-mouse mixed lymphocyte cultures.Immunology1978https://conductscience.org/library/papers/151664PubMed
134,125Genetic and cellular aspects of xenogeneic mixed leukocyte culture reaction.J Exp Med1976https://conductscience.org/library/papers/134125PubMed
85,255Recognition of antigens by T lymphocytes.Mol Cell Biochem1978https://conductscience.org/library/papers/85255PubMed
75,235
Induction of specific immune unresponsiveness with purified mixed leukocyte culture-activated T lymphoblasts as autoimmunogen. II. An analysis of the effects measured at the cellular and serological levels.
J Exp Med1978https://conductscience.org/library/papers/75235PubMed
69,009Cytotoxic T lymphocytes induced against allogeneic I-region determinants react with Ia molecules on trinitrophenyl-conjugated syngeneic target cells.J Exp Med1977https://conductscience.org/library/papers/69009PubMed
67,179Cytotoxic T lymphocytes specific for I region determinants do not require interactions with H-2K or D gene products.J Exp Med1977https://conductscience.org/library/papers/67179PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/58457

GET https://conductscience.org/api/papers/v1/58457/authors